Acting Attorney General Todd Blanche said he is immediately moving medical marijuana from Schedule I to Schedule III, which includes drugs like ketamine, Tylenol with codeine and anabolic steroids.

As was roughly anticipated, the Trump administration has moved to partially reclassify marijuana, announcing on Thursday that state-licensed medical marijuana will now be considered a less dangerous drug.

The Trump administration is reclassifying state-licensed medical marijuana as a less dangerous drug, and also giving licensed operators a major tax break in a historic policy shift.

The DOJ’s move to reclassify some forms of marijuana pick up where the Biden administration left off, pushing the broader reclassification process forward. In 2023, Biden’s Department of Health and Human Services recommended that marijuana be reclassified as a Schedule III drug,

Acting Attorney General Todd Blanche signed an order Thursday to reclassify state-licensed medical marijuana as a less dangerous drug. The order shifts the designation of licensed medical marijuana from a high level of regulation to a much looser level.

On Thursday the Trump administration officially reclassified state-licensed medical marijuana products under the Controlled Substances Act (CSA). The move removes these products from the Schedule I

Acting Attorney General Todd Blanche issues a final order moving medical cannabis products to Schedule III, following a 2025 executive order.

President Donald Trump highlighted the medical benefits of marijuana on Thursday, hours after the Department of Justice announced it is moving ahead with a cannabis rescheduling proposal. “A lot of people are suffering from big problems,

The action is one of the most consequential federal marijuana policy changes in decades and could lend new legitimacy to regulated medical marijuana programs operating in more tha